Evaluation of Blood Pressure among Chronic Hemodialysis Patients and Current Approaches in Its Treatment

Yıl 2007, Cilt: 16 Sayı: 2, 83 - 99, 01.06.2007

Fadime Ersoy Dursun Ali İhsan Günal

Öz

No abstract available

Anahtar Kelimeler

Hemodialysis, Chronic Renal Disorder, Treatment

Kronik Hemodiyaliz Hastalarında Kan Basıncının Değerlendirilmesi ve Tedavisinde Güncel Yaklaşımlar

Öz

Anahtar Kelimeler

Hemodiyaliz, KBY, Tedavi

Kaynakça

• Imai Y, Sekino H, Fujikura Y, et al Pressor effect of recombinant human erythropoietin: results of ambulatory blood pressure monitoring and home blood pressure measurements. Clin Exp Hypertens. 1995; 17: 485–506.
• Agarwal R. Assessment of Blood Pressure İn Hemodialysis Patients. Seminars in Dialysis. 2002; 15: 299–304
• Townsend RR, Ford V. Ambulatory blood pressure monitoring: coming of age in nephrology. J Am Soc Nephrol. 1996; 7: 2279–2287.
• Peixoto AJ, Sica DA. Ambulatory blood pressure monitoring in end-stage renal disease. Blood Press Monit. 1997; 2: 275–282.
• Mansoor GA, White WB. Ambulatory blood pressure monitoring is a useful clinical tool in nephrology. Am J Kidney Dis. 1997;30: 591–605.
• Erturk S, Ertug AE, Ates K et al Relationship of ambulatory blood pressure monitoring data to echocardiographic findings in haemodialysis patients. Nephrol Dial Transplant. 1996; 11: 2050–2054.
• Lingens N, Soergel M, Loirat C, et al Ambulatory blood pressure monitoring in paediatric patients treated by regular haemodialysis and peritoneal dialysis. Pediatr Nephrol. 1995; 9: 167–172.
• Mancia G, Frattola A, Groppelli A, et al Blood pressure reduction and end organ damage in hypertension. J Hypertens. 1994; Suppl 12:S35-S42.
• Siche JP, Schwebel C, Longere P, et al Left ventricular hypertrophy and blood pressure variability during rest and ambulatory monitoring in the hypertensive patient . Arch Mal Coeur Vaiss. 1994; 87: 1005–1009.
• Pai PY, Chou HT, Tsou SS, et al The prognostic value of ambulatory blood pressure monitoring in untreated mild-to-moderate hypertensive patients: Correlation with echocardiography. Zhonghua Yi Xue Zhi (Taipei). 1994; 54: 93–99.
• Martin LC, Franco RJ, Gavras I, et al. Is 44-hour better than 24-hour ambulatory blood pressure monitoring in hemodialysis Kidney Blood Press Res. 2006; 29: 273– 279.
• Amar J, Vernier I, Rossignol E, et al Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000; 57: 2485–2491.
• Covic A, Goldsmith DJ, Covic M. Reduced blood pressure diurnal variability as a risk factor for progressive left ventricular dilatation in hemodialysis patients. Am J Kidney Dis. 2000; 35: 617–623.
• Pejcic I, Peco-Antic A, Parezanovic V, et al Continuous blood pressure monitoring over a 24- hour period in children with terminal renal failure treated with hemodialysis. Srp Arh Celok Lek. 1996; (suppl 1) 124: 94–96.
• Huisman RM, de Bruin C, Klont D, et al Relationship between blood pressure during haemodialysis and ambulatory blood pressure in between dialyses. Nephrol Dial Transplant. 1995; 10: 1890–1894.
• O’Brien E, Sheridan J, O’Malley K: Dippers and nondippers. Lancet. 1988; 2: 397.
• Campbell NR, McKay DW, Chockalingam et al Errors in assessment of blood pressure: Blood pressure measuring technique. Can J Public Health. 1994; (suppl 2) 85:S18-S21.
• Kooman JP, Gladziwa U, Bocker G, et al Blood pressure during the interdialytic period in haemodialysis patients: estimation of representative blood pressure values. Nephrol Dial Transplant. 1992; 7: 917–923.
• Franklin SS, Larson MG, Khan SA et al Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation. 2001; 103:1245– 1249.
• Amar J, Vernier I, Rossignol E et al Influence of nycthemeral blood pressure pattern in treated hypertensive patients on hemodialysis.Kidney Int. 1997; 5: 1863–1866.
• Amar J, Vernier I, Rossignol E, et al Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000; 57: 2485–2491.
• Shimada K, Kawamoto A, Matsubayashi K et al: Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992; 10: 875–
• Verdecchia P, Schillaci G, Boldrini F et al Sex, cardiac hypertrophy and diurnal blood pressure variation in essential hypertension. J Hypertens 1992; 10: 683–692.
• Prakash S, Chibber SK, Prakash S, et al. Assessment of hypertension control in chronic kidney disease patients by ambulatory blood pressure monitoring. J Assoc Physicians India. 2005 ; 53: 769–774.
• Ozcakar ZB, Yalcinkaya F, Tutar E, et al. Hypertension and left ventricular hypertrophy in pediatric peritoneal dialysis patients: ambulatory blood pressure monitoring and echocardiographic evaluation. Nephron Clin Pract. 2006;104:101–106.
• Hoshide S, Korio K, Hoshide Y, et al Associations Betwwen Nondipping of Nocturnal Blood Pressure Decrease and Cardiovascular Target Organ Damage in Strictly Selected Community- Dwelling Normotensives. Am J Hypertens. 2003; 16: 434–438
• Mac Gregor GA: Sodium is more important than calcium in essential hypertension. Hypertension 1985; 7: 628–640.
• Hofman A, Hazebroek A, Valkenburg HA: A randomized trial of sodium intake and BP in newborn infants. JAMA. 1983; 250: 370– 73.
• Ball CO, Meneely GR: Observations on dietary, sodium chloride. J Am Diet Assoc 1957; 33: 366–370
• National Survey on Circulatory Disorders. Kosheisho, Japan: Ministry of Health and Welfare, 1980 .
• Joossens JV, Geboers J: Salt and hypertension. Prev Med 1983;12: 53– 59.
• Beretta-Picolli C, Weidman P, de Chatel P: Hypertension associated with early end-stage kidney disease. Am J Med 1976;61: 739–747.
• Charra B, Chazot C: Volume control, blood pressure and cardiovascular function. Nephron Physiol 2003; 93: 94–101.
• Mitch W, Wilcox CS: Disorders of bodily fluids, sodium and potassium in chronic renal failure. Am J Med. 1982; 72: 536–550.
• Weidmann P, Reubi F. Renal hypertension. Schweiz Med Wochenschr. 1976; 06: 1778– 1790.
• Koomans HA, Geers AB, Boer P: A study on the distribution of body fluid after rapid saline expansion in normal subjects and in patients with renal insufficiency: preferential intravascular deposition in renal failure. Clin Sci. 1983; 64: 153–160.
• Powis DA, Donald DE: Involvement of renal alpha and beta adrenoceptors in release of renin by carotid baroreflex. Am J Physiol. 1979; 236: 580–585.
• Koomans HA, Roos JC, Boer P et al Salt sensitivity of blood pressure in chronic renal failure: evidence for renal control of body fluid distribution in man. Hypertension. 1982; 4: 190–197.
• Vertes V, Cangiano JL, Berman LB: Hypertension in end-stage renal disease. N Engl J Med. 1969; 280: 978 – 981.
• Ozkahya M, Toz H, Unsal A et al Treatment of hypertension in dialysis patients by ultrafiltration: role of cardiac dilatation and time factor. Am J Kidney Dis. 2001; 34: 218–221.
• Gunal AI, Duman S, Ozkahya et al Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis. 2001; 37: 588–593.
• Charra B: “Dry weight” in dialysis: the history of a concept. Nephrol Dial Transplant 1998; 13: 1882 –1885.
• Chazot C, Charra B, Vo VC: The Janus-faced aspect of dry weight. Nephrol Dial Transplant 1999; 14: 121–124.
• Katzarski KS, Charra B, Luik AJ: Fluid state and blood pressure control in patients treated with long and short hemodialysis. Nephrol Dial Transplant 1999; 14: 369–375.
• Rigby-Mathews A, Scribner BH, Ahmad S: Control of interdialytic weight gain (IDWG) without water restriction in hemodialysis patients. J Am Soc Nephrol. 1999; 10: A1348.
• Ozkhaya M, Toz H, Ozerkan F et al Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol. 2002; 15: 655–660.
• Ates K, Nerzgizoglu G, Keven K et al Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int. 2001; 60: 767–776.
• Scribner BH: Adequate control of blood pressure in patients on chronic hemodialysis [editorial]. Kidney Int. 1992; 41: 1286.
• Blumberg A, Nelp WB, Hegstrom RM et al. Extacellular volume in patients with chronic renal disease treated for hypertension by sodium restriction. The Lancet. 1967; 2: 69–73
• Wu CC, Lin YP, Yu WC et al The assessment of fluid status in haemodialysis patients: usefulness of the Doppler echocardiographic parameters. Nephrol Dial Transplant. 2004; 19: 644–651
• Zucchelli P, Santoro A. Dry weight in hemodialysis: volemic control. Semin Nephrol. 2001; 21: 286–290
• Jaeger JQ, Mehta RL. Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol 1999; 10: 392–403
• Charra B, Bergstrom J, Scribner BH. Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis. 1998; 32: 720–724.
• Feehally J, Johnson R. Comprehensive Clinical Nephrology. Mosby. 2002; 14: 887–904
• Spiegel DM, Bashir K, Fisch B. Bioimpedance resistance ratios for the evaluation of dry weight in hemodialysis. Clin Nephrol. 2000; 53: 108–114
• Ronco C, Brendolan A, Milan M. Impact of biofeedback-induced cardiovascular stability on hemodialysis tolerance and efficiency. Kidney Int. 2000; 58: 800–808.
• Charra B, Chazot C: Volume control, blood pressure and cardiovascular function. Nephron Physiol. 2003; 93: 94–101.
• Guyton AC, Hall JE, Coleman G et al The dominant role of the kidneys in the long-term regulation of arterial pressure in normal hypertensive states. Hypertension: Pathophysiology, Diagnosis and Management. Raven Press, New York, NY: 1990: 1029–1052.
• Blumberg A, Hegstrom RM, Nelp WB: Extracellular volume and exchangeable sodium in chronic hypertensive renal disease. In: Kerr DNS. Pro-ceedings of the European Dialysis Transplant Association. Newcastle Upon-Tyne, UK: Scheltema and Holima, 1964: 192 – 203.
• Wizemann V, Kramer W: Short-term dialysis long-term complications: Ten years experience with short-duration renal replacement therapy. Blood Purif. 1987; 5: 193–201.
• Scribner BH: A personalized history of chronic hemodialysis. Am J Kidney Dis. 1990; 6: 511– 519.
• Charra B, Calemard E, Cuche M: Control of hypertension and prolonged survival on maintenance hemodialysis. Nephron.1983; 33: 96–99.
• Charra B, Laurent G, Chazot C: Clinical assessment of dry weight. Nephrol Dial Transplant. 1996; 11: 16–19.
• Fishbane SA, Scribner BH: Blood pressure control in dialysis patients. Semin Dial. 2002; 15: 144–145.
• Krautzig S, Janssen U, Koch KM, Granolleras C: Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant. 1998; 13: 552–553.
• Converse RL Jr, Jacobsen TN, Jost CM, et al: Paradoxical with drawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest. 1992; 90: 1657–1665.
• Cannella G, Paoletti E, Delfino R et al Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects Am J Kidney Dis. 1997; 30: 659–664.
• Efrati S, Zaidenstein R, Dishy V, et al. ACE inhibitors and survival of hemodialysis patients. Am J Kidney Dis 2002; 40: 1023–1029.